Halozyme Therapeutics, Inc. (HALO) Free Cash Flow
Halozyme Therapeutics, Inc. (HALO) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | -$53.53M |
| 2017-12-31 | $132.74M |
| 2018-12-31 | -$54.15M |
| 2019-12-31 | -$89.46M |
| 2020-12-31 | $54.03M |
| 2021-12-31 | $297.98M |
| 2022-12-31 | $235.30M |
| 2023-12-31 | $373.28M |
| 2024-12-31 | $468.37M |
| 2025-12-31 | $644.59M |
How HALO compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| NBIX | Neurocrine Biosciences Inc. | $748.70M |
| BMRN | BioMarin Pharmaceutical Inc. | $717.02M |
| ENSG | The Ensign Group Inc. | $564.27M |
| ALGN | Align Technology Inc. | $490.78M |
| ALNY | Alnylam Pharmaceuticals Inc. | $465.38M |
These are five companies in the same sector as HALO with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Halozyme Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("HALO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HALO | $106.92 | -0.13% | 1.36M |
| 3 | ||||
| 4 | ||||
| 5 |